IndraLab

Statements

DAS181 inhibits OTUD4. 1 / 1

| 1

reach

"A randomized, double-blind, placebo-controlled phase II clinical study revealed that DAS181 significantly reduced viral load in individuals infected with influenza viruses such as seasonal H3N2, pande[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

38160620

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

DAS181 inhibits OTUD4. 1 / 1

INDRA sources:

Databases

Reading